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an adenine insertion in locus rs10305936. The frequencies of A
homozygote, A heterozygote and no insertion genotype on case group
and control group were 7.5%, 81.1%, and 11.3% and 0%, 98.0%, and 2.0%
respectively, and the difference between these two groups were of
statistical signiﬁcance (&chi2 = 7.88, P = 0.019). (2) There were no
statistically signiﬁcant differences in genotypewithin steroid resistant
NS group and non-steroid resistant NS group and hypertension group
and non-hypertension group (P N 0.05). Conclusions: There is an
adenine insertion in locus rs10305936. The endothelin-A receptor
gene polymorphisms in locus rs10305936 are related to the morbidity
of nephrotic syndrome in children.
doi:10.1016/j.lfs.2014.01.053
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Backgrounds: Chronic thromboembolic pulmonary hypertension
(CTEPH) is characterized by stenosis and obstruction of pulmonary
artery with non-resolving organized thromboemboli, leading to
elevated pulmonary vascular resistance (PVR) and right heart failure.
Endothelin (ET) system is closely correlated with the hemodynamic
severity in patients with CTEPH, and serum ET-1 level can be a
marker to predict clinical outcome. Recently, balloon pulmonary
angioplasty (BPA) for non-operable CTEPH patients is establishing.
Our objective was to study the dynamics of ET system by measuring
serum ET-1 and big ET-1 levels in CTEPH patients who underwent BPA
and assess the relationship between ET system and hemodynamics with
orwithout ET receptor antagonists (ERAs).Methods: BPAwas performed
on thirteen patients diagnosed as non-operable CTEPH (22 sessions;
baseline mean pulmonary arterial pressure, 36.1 ± 9.9 mmHg; cardiac
index (C.I.), 2.44 ± 0.56 l/min/m2; medical therapy with ERAs, 50%).
Samples were collected before and after BPA from radial artery and
pulmonary artery. SerumET-1 and big ET-1 levels weremeasured using
enzyme-linked immunosorbent assay and analyzedwith hemodynamic
data measured by right heart catheterization. Results: At baseline, not
only serum ET-1 but also big ET-1 levels were higher in ERA group than
in non-ERA group. ET-1 and big ET-1 levels were signiﬁcantly increased
after BPA and decreased to baseline levels in about one week. In ERA
group, C.I. post BPA was higher than that in non-ERA group and
signiﬁcantly and strongly correlated with ET-1 and big-ET-1 levels.
Conclusions: Elevated serum ET-1 and big ET-1 levels in CTEPH patients
with ERAs can be markers to predict better hemodynamics after BPA.
doi:10.1016/j.lfs.2014.01.054
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Purpose: To evaluate whether BQ788 has beneﬁcial action on
the septic brain. Methods: We prepared the raw fecal ﬂuid from
soft stool of mice. C57BL/6J mice were randomly divided into
three groups as follows: pre-PBS + raw fecal ﬂuid group (Fresh
group); pre-BQ788 + raw fecal ﬂuid group (BQ group); and pre-
BQ788 + PBS group (PBS group). According to each experimental
condition, PBS or BQ788 was intravenously injected to mice prior to
the i.p. administration of the fecal ﬂuid or PBS. All groups of mice
were sacriﬁced at 8 h after administration, and then the brain and
peripheral blood samples were prepared. Results: In Fresh group, an
enhanced expression of c-FOS was observed in the paraventricular
nucleus of both the thalamus and hypothalamus, and an increase
of apoptotic neuroblasts was determined in the SGZ of the dentate
gyrus, compared with PBS group. In the corresponding region
to their ﬁndings, the number of reactive microglia and vascular
permeability were markedly increased. BQ788 inhibited the induc-
tion of c-FOS expression, neuroblast apoptosis and reactive microglia
without affecting the vascular leakage. Furthermore, western blot
array analysis of peripheral blood from each group showed that various
proinﬂammatory cytokines were elevated like a cytokine storm in the
serum from Fresh group. This typical induction of cytokines was
insensitive to the treatment with BQ788. Discussion: In the present
study, we demonstrated that BQ788 could protect the brain from sepsis-
associated pathophysiological inputs as follows: neural cell death,
inﬂammatory response and the Hans Selye's environmental stress
reaction. We will discuss the mode of action of BQ788 in the brain.
doi:10.1016/j.lfs.2014.01.055
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Endothelin (ET)-1 plays a role as a pro-inﬂammatory mediator
and a marker of endothelial dysfunction and is known to be involved
in the pathogenesis of acute lung injury (ALI). Systemic administra-
tion of some ET receptor antagonists (ETRAs) has been beneﬁcial
in various experimental ALI cases, particularly in sepsis-induced
models. However, there are few studies to assess whether intra-
tracheal administration of ETRAs has therapeutic beneﬁt in ALI
models caused by pulmonary disease. Likewise, the relationships
between ET signaling and production of proinﬂammatory cytokines
in the pathogenesis of ALI are still unknown. To determine whether
intratracheal administration of ETRAs has anti-inﬂammatory effect
on pulmonary inﬂammation in vivo, we induced ALI in mice by
intratracheal instillation of LPS in combination with BQ123 or BQ788.
Then, we examined lung histopathological changes and differential
cell counts and a comprehensive cytokine expression proﬁle in
bronchoalveolar lavage ﬂuid (BALF) from mice 12 h after LPS
instillation with or without the drugs. The LPS-induced neutrophilic
inﬁltration into alveoli was inhibited by both BQ123 and BQ788.
Accordingly, a marked increase of total cell count and segmented
neutrophil content in BALF from mice challenged with LPS was
signiﬁcantly inhibited by the BQs. LPS induced several cytokines as
follow, IL-6, G-CSF, sTNFRs, RANTES and so on, which were inhibited
by the BQs. These results suggest that intratracheal administration
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of ETRAs may be a potentially useful treatment for ALI caused by
pneumonia.
doi:10.1016/j.lfs.2014.01.056
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Endothelin (ET)-1 plays pleiotropic roles under the pathological
conditions including hypertension, atherosclerosis, heart failure, cancer
development and so on. Also in adaptive immune system, it has been
reported that ET-1 could regulate function of dendritic cells (DCs, one
of antigen-presenting cells) through the ET-1/ETA/ETB autocrine/
paracrine loops. To date, however, a role of ET in autoimmune disease
has not been elucidated. Here, we focused on IL-17 closely related to the
pathogenesis ofmultiple sclerosis (MS) and investigated the effect of ET
receptor blockers on the production of IL-17 from T lymphocytes.
Lymph node cells (LNC) from mice at 8 days post-immunization with
MOG35–55were stimulated in vitrowithMOG35–55 in the presence or
absence of ETR blocker (BQ123 or BQ788). An enzyme-linked
immunosorbent assay revealed that the MOG35–55-induced IL-17
production was signiﬁcantly inhibited by BQ123 but not BQ788.
Consistent with ELISA for IL-17, the frequency of CD4+ T cells
producing IL-17 was reduced by BQ123. To further elucidate the
mechanism for ET-mediated IL-17 production, in vitro model of Th17
differentiationwas conducted. In condition medium of naïve T cells put
under the differentiating condition for 72 h, the spontaneous release of
IL-17 was increased, which was insensitive to BQ123. After the 72 h-
differentiation, however, the anti-CD3/CD28 antibodies-induced IL-17
production from T cells was signiﬁcantly inhibited by BQ123. These
results suggest that ET/ETA signaling plays a crucial role in IL-17
production from Th17 and that BQ123 might be expected as a future
therapeutic drug for the MS.
doi:10.1016/j.lfs.2014.01.057
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Objective: In recent years, several studies demonstrated that
bosentan induced clinical and hemodynamic improvement in candi-
dates for right heart bypass surgery. We hypothesized that the
endothelin system may play an important role in maintaining
vasoconstriction in single ventricular physiology before and after right
heart bypass surgery. Methods: Lung biopsy samples from two patients
were subjected to immunohistological analysis. The ﬁrst patient was a
27-year-old female who underwent atrio-pulmonary connection for
tricuspid atresia at 4 years of age. A huge thrombus was noted on an
echocardiogram in the markedly enlarged right atrium. She underwent
the conversion to total cavopulmonary connection. The second
patient was a 3-year-old girl with asplenia syndrome. She underwent
bidirectional Glenn shunt at the age of 10 months. She had bosentan
and beraprost therapy for elevated pulmonary artery pressure and
pulmonary vascular resistance for 33 months. She underwent total
cavopulmonary connection at 3 years of age. Results: Patient 1: strong
positive immunostaining for endothelin-1 (ET-1) was present in
endothelial cells of capillary vessels in this failed Fontan patient, whereas
in normal control, only veryweak staining of ET-1 in endothelial cellswas
observed. Patient 2: there were many ET-1 positive cells in the
interstitium of alveolar wall. Most, but not all, of these cells expressed
endothelin converting enzyme-1. Conclusions: The endothelin system
may have distinct roles in the pulmonary circulation in patients with
single ventricular physiology. The results of this preliminary study
warrant further investigations.
doi:10.1016/j.lfs.2014.01.058
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